FDA inspection

Recipharm Pessac: FDA inspection ending Jun 28, 2024

FDA inspection 1268454 · Voluntary Action Indicated (VAI) · Pessac

Key facts

Inspection ID 1268454
Firm Recipharm Pessac
FEI number 3011269473
Address 11 Avenue Gustave Eiffel
City Pessac
Country France
Fiscal year 2024
Inspection end date Jun 28, 2024
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections